BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a Novel Series of Potent SHP2 Allosteric Inhibitors.EBI
IRBM
Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors.EBI
IRBM
SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.EBI
Irbm
Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction.EBI
Irbm
Discovery of 4-((1-(1H-imidazol-2-yl)alkoxy)methyl)pyridines as a new class of Trypanosoma cruzi growth inhibitors.EBI
Irbm
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein.EBI
Irbm
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction.EBI
Irbm
CARBONYL HETEROCYCLIC COMPOUND AND APPLICATION THEREOFBDB
Shanghai Pharmaceuticals Holding Co.